サウスカロライナにおける潰瘍性大腸炎の臨床試験
サウスカロライナ内の拠点で、潰瘍性大腸炎に関する12件の研究が参加者を募集しています。
サウスカロライナ内の都市
公式研究テキスト（英語）
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Patewood Medical Campus /ID# 272477, Greenville
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/30更新 · NCT07071519A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0099, Charleston
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Associates - Patewood, Greenville
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Associates, P.A. of Greenville, Greenville
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Medical University of South Carolina, Charleston
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Biocentric Health Research Partner, West Columbia
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Columbia Digestive Health Research (Objective Health), Columbia
被験者募集中
18歳〜85歳 · 全性別 · 2026/08/06更新 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/03更新 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Medical University of South Carolina (MUSC), Charleston
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。